1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The phase 3 NETTER-1 study of (177)Lu-DOTATATE in patients with midgut neuroendocrine tumors: Updated progression-free survival analyses
    Meeting Abstract

    Kunz, P. L.; Benson, A.; Bodei, L.; Grande, E.; Mittra, E.; Kulke, M. H.; Yao, J. C.; Wolin, E. M.; Niepel, D.; Demange, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schöder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Novel [(124)I]ATRi VE-821 analogue PET tracer in mouse models for prostate cancer
    Meeting Abstract

    Artschwager, R.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Synthesis and evaluation of a bivalent radiohapten for DOTA-based pretargeted radioimmunotherapy
    Meeting Abstract

    Veach, D.; Vaughn, B.; Vargas, D. B.; Seo, S.; Punzalan, B.; Xu, H.; Guo, H. F.; Krebs, S.; Yang, G.; Ouerfelli, O.; more...
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Preclinical development of [(89)Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas
    Meeting Abstract

    Herrero Alvarez, N.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Cholesterol-depleting drugs for HER2-targeted radioimmunotherapy of patient-derived esophagogastric (EG) cancer
    Meeting Abstract

    Rao, Y.; Pereira, P.; Samuels, Z.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Detecting EGFR expression in bladder cancer using [(89)Zr]Zr-DFO-Panitumumab immunoPET imaging
    Meeting Abstract

    Hoang, T.; Mandleywala, K.; Tan, K.; Pereira, P.; Lewis, J.
    Nuclear Medicine and Biology (2022)

    Fulltext@MSK | Save
  • Development of an automated region of interest selection algorithm for surface guided radiation therapy of breast cancer
    Meeting Abstract

    Cui, S.; Li, G.; Kuo, H.; Zhao, B.; Li, A.; Cervino, L.
    Medical Physics (2022)

    Fulltext@MSK | Save
  • Use of natural language processing for assisted review of clinical trial protocols
    Meeting Abstract

    Liu, X.; Hazoglou, M.
    Medical Physics (2022)

    Fulltext@MSK | Save